Avid Bioservices, Inc.

NasdaqCM:CDMO Voorraadrapport

Marktkapitalisatie: US$678.1m

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Avid Bioservices Beheer

Beheer criteriumcontroles 3/4

De CEO Avid Bioservices' is Nick Green, benoemd in Jul2020, heeft een ambtstermijn van 4.25 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 4.48M, bestaande uit 14.5% salaris en 85.5% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.33% van de aandelen van het bedrijf, ter waarde $ 2.42M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 4.6 jaar en 5.3 jaar.

Belangrijke informatie

Nick Green

Algemeen directeur

US$4.5m

Totale compensatie

Percentage CEO-salaris14.5%
Dienstverband CEO4.3yrs
Eigendom CEO0.3%
Management gemiddelde ambtstermijn4.6yrs
Gemiddelde ambtstermijn bestuur5.3yrs

Recente managementupdates

Recent updates

Is Avid Bioservices (NASDAQ:CDMO) Using Too Much Debt?

Aug 26
Is Avid Bioservices (NASDAQ:CDMO) Using Too Much Debt?

Avid Bioservices, Inc. (NASDAQ:CDMO) Surges 43% Yet Its Low P/S Is No Reason For Excitement

Jul 29
Avid Bioservices, Inc. (NASDAQ:CDMO) Surges 43% Yet Its Low P/S Is No Reason For Excitement

There's No Escaping Avid Bioservices, Inc.'s (NASDAQ:CDMO) Muted Revenues Despite A 40% Share Price Rise

Mar 07
There's No Escaping Avid Bioservices, Inc.'s (NASDAQ:CDMO) Muted Revenues Despite A 40% Share Price Rise

We Think Avid Bioservices (NASDAQ:CDMO) Has A Fair Chunk Of Debt

Feb 28
We Think Avid Bioservices (NASDAQ:CDMO) Has A Fair Chunk Of Debt

There's No Escaping Avid Bioservices, Inc.'s (NASDAQ:CDMO) Muted Revenues Despite A 39% Share Price Rise

Dec 28
There's No Escaping Avid Bioservices, Inc.'s (NASDAQ:CDMO) Muted Revenues Despite A 39% Share Price Rise

Does Avid Bioservices (NASDAQ:CDMO) Have A Healthy Balance Sheet?

Nov 10
Does Avid Bioservices (NASDAQ:CDMO) Have A Healthy Balance Sheet?

Calculating The Intrinsic Value Of Avid Bioservices, Inc. (NASDAQ:CDMO)

Oct 15
Calculating The Intrinsic Value Of Avid Bioservices, Inc. (NASDAQ:CDMO)

Time To Worry? Analysts Are Downgrading Their Avid Bioservices, Inc. (NASDAQ:CDMO) Outlook

Jun 23
Time To Worry? Analysts Are Downgrading Their Avid Bioservices, Inc. (NASDAQ:CDMO) Outlook

Is Avid Bioservices (NASDAQ:CDMO) Using Too Much Debt?

Jun 12
Is Avid Bioservices (NASDAQ:CDMO) Using Too Much Debt?

Little Excitement Around Avid Bioservices, Inc.'s (NASDAQ:CDMO) Earnings As Shares Take 26% Pounding

May 21
Little Excitement Around Avid Bioservices, Inc.'s (NASDAQ:CDMO) Earnings As Shares Take 26% Pounding

Are Investors Undervaluing Avid Bioservices, Inc. (NASDAQ:CDMO) By 49%?

May 12
Are Investors Undervaluing Avid Bioservices, Inc. (NASDAQ:CDMO) By 49%?

Does Avid Bioservices (NASDAQ:CDMO) Have A Healthy Balance Sheet?

Mar 13
Does Avid Bioservices (NASDAQ:CDMO) Have A Healthy Balance Sheet?

Here's Why Avid Bioservices (NASDAQ:CDMO) Has A Meaningful Debt Burden

Nov 10
Here's Why Avid Bioservices (NASDAQ:CDMO) Has A Meaningful Debt Burden

Avid Bioservices GAAP EPS of $0.02 beats by $0.01, revenue of $36.7M beats by $3.26M

Sep 06

Laughing Water Capital - Avid Bioservices: Not A Binary Bet But A Real Business

Jul 27

Avid Bioservices GAAP EPS of $1.65 beats by $1.65, revenue of $31M beats by $2.04M

Jun 29

Analyse CEO-vergoeding

Hoe is Nick Green's beloning veranderd ten opzichte van Avid Bioservices's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jul 31 2024n/an/a

-US$144m

Apr 30 2024US$4mUS$650k

-US$141m

Jan 31 2024n/an/a

-US$18m

Oct 31 2023n/an/a

-US$12m

Jul 31 2023n/an/a

-US$3m

Apr 30 2023US$6mUS$642k

US$259k

Jan 31 2023n/an/a

US$116m

Oct 31 2022n/an/a

US$119m

Jul 31 2022n/an/a

US$123m

Apr 30 2022US$6mUS$600k

US$128m

Jan 31 2022n/an/a

US$10m

Oct 31 2021n/an/a

US$9m

Jul 31 2021n/an/a

US$6m

Apr 30 2021US$3mUS$421k

US$3m

Compensatie versus markt: De totale vergoeding ($USD 4.48M ) Nick } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 3.23M ).

Compensatie versus inkomsten: De vergoeding van Nick is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Nick Green (59 yo)

4.3yrs

Tenure

US$4,475,343

Compensatie

Mr. Nicholas Stewart Green, also known as Nick, B.Sc., MBA, has been the President, Chief Executive Officer and Director at Avid Bioservices, Inc. since July 30, 2020. He served as the Chief Executive Offi...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Nicholas Green
President4.3yrsUS$4.48m0.33%
$ 2.3m
Daniel Hart
Chief Financial Officer6.3yrsUS$1.44m0.13%
$ 894.9k
Richard Richieri
Chief Operations Officer5yrsUS$883.93k0.065%
$ 437.8k
Mark Ziebell
VP, General Counsel & Corporate Secretary12.3yrsUS$1.03m0.10%
$ 710.1k
Matthew Kwietniak
Chief Commercial Officer3yrsUS$975.87k0.037%
$ 248.9k
Oksana Lukash
Vice President of People2.8yrsgeen gegevensgeen gegevens

4.6yrs

Gemiddelde duur

59yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van CDMO wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.6 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Nicholas Green
President4.3yrsUS$4.48m0.33%
$ 2.3m
Joseph Carleone
Independent Chairman6.9yrsUS$275.19k0.16%
$ 1.1m
Catherine Mackey
Independent Director5.3yrsUS$245.19k0.026%
$ 176.7k
Gregory Sargen
Independent Director6.9yrsUS$245.19k0.015%
$ 102.2k
Jeanne Thoma
Independent Director3.8yrsUS$245.19k0.030%
$ 200.5k
Richard Hancock
Director6.9yrsUS$240.19k0.18%
$ 1.2m
Esther Alegria
Independent Director3.3yrsUS$240.19k0.017%
$ 116.8k

5.3yrs

Gemiddelde duur

65yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van CDMO wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.3 jaar).